Graham A. Branscom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Graham A. Branscom has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Evan M. Ren
4 shared publications- Keshv Krishna Srinivasan
Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York
3 shared publications Matthew T. Carr
3 shared publicationsMichael B. Lemonick
3 shared publicationsAlexander J. Schupper
Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York
2 shared publications- Bahie Ezzat
Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York
2 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Elsevier in World Neurosurgery
- Vol. 216
The Top 100 Most Cited Articles on Posterior Cervical Foraminotomies: A Bibliometric Analysis
- 23 September 2026
- Published by Elsevier in World Neurosurgery
- Vol. 216
Open AccessThe Top 100 Most Cited Articles on Posterior Cervical Foraminotomies: A Bibliometric Analysis
- Open Access
- 7 September 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12 (10)
Spinal myxopapillary ependymoma arising directly from a lumbar nerve root: illustrative case
BACKGROUND: Myxopapillary ependymoma (MPE) is a rare primary neoplasm found in the brain and spinal cord that develops from ependymal cells. This tumor type has a prevalence of around 1 in 1 million persons, constitutes 1%–5% of all spinal tumors, and typically arises from the conus medullaris or cauda equina. Prognosis is generally favorable if treated appropriately with resection and, in the event of subtotal resection, radiation therapy. However, MPEs carry a risk of growing or spreading along the neural axis, so timely diagnosis and treatment are crucial. OBSERVATIONS: The authors present a unique presentation of an MPE arising directly from a nerve root at the L1–2 level. Radiographic imaging displayed an intradural extramedullary (IDEM) mass with resultant cord compression; corresponding neurological deficits prompted resection, and gross-total resection was achieved. A subsequent review of the literature identified diagnostic criteria, usual presenting features, and treatment strategies. LESSONS: MPE can be a treatable pathology, with most patients having a favorable prognosis. This tumor type should remain in the differential diagnosis when encountering IDEM lesions superior to the conus medullaris or along spinal roots. Early identification and surgical treatment with maximal resection are crucial to prevent tumor spread. https://thejns.org/doi/10.3171/CASE26297
- 7 September 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12 (10)
Open AccessSpinal myxopapillary ependymoma arising directly from a lumbar nerve root: illustrative case
BACKGROUND: Myxopapillary ependymoma (MPE) is a rare primary neoplasm found in the brain and spinal cord that develops from ependymal cells. This tumor type has a prevalence of around 1 in 1 million persons, constitutes 1%–5% of all spinal tumors, and typically arises from the conus medullaris or cauda equina. Prognosis is generally favorable if treated appropriately with resection and, in the event of subtotal resection, radiation therapy. However, MPEs carry a risk of growing or spreading along the neural axis, so timely diagnosis and treatment are crucial. OBSERVATIONS: The authors present a unique presentation of an MPE arising directly from a nerve root at the L1–2 level. Radiographic imaging displayed an intradural extramedullary (IDEM) mass with resultant cord compression; corresponding neurological deficits prompted resection, and gross-total resection was achieved. A subsequent review of the literature identified diagnostic criteria, usual presenting features, and treatment strategies. LESSONS: MPE can be a treatable pathology, with most patients having a favorable prognosis. This tumor type should remain in the differential diagnosis when encountering IDEM lesions superior to the conus medullaris or along spinal roots. Early identification and surgical treatment with maximal resection are crucial to prevent tumor spread. https://thejns.org/doi/10.3171/CASE26297
- Open Access
- 18 July 2026
- Published by Springer Nature in Cureus
- Vol. 18 (7)
Investigating Intracerebral Hemorrhage Evacuation Procedure Volumes Before and After the Minimally Invasive Surgery Plus Alteplase for Intracerebral Hemorrhage Evacuation III (MISTIE III) Trial
Introduction Intracerebral hemorrhage (ICH) constitutes 10-15% of all strokes in the United States and has a 30-40% mortality rate. The Minimally Invasive Surgery Plus Alteplase for Intracerebral Hemorrhage Evacuation III (MISTIE III) trial showed no significant functional benefit of minimally invasive catheter drainage (MICD) and postoperative thrombolysis compared to medical management. Our objective is to evaluate how the results of the MISTIE III trial corresponded to changes in ICH evacuation procedure volumes. Materials and methods We used an aggregated dataset containing Medicare Part B procedure data from 2013 to 2023. We calculated the normalized volume of MICD procedures, supratentorial craniotomies, and infratentorial craniotomies for ICH evacuation. We normalized the volumes by calculating the percentage of all neurosurgical procedures that included ICH evacuation for each year. We used an interrupted time series (ITS) to find statistically significant changes in volumes before (βpre) and after (βpost) 2019, when the MISTIE III results were published. Results Normalized MICD volumes increased slightly before 2019 (βpre = 0.0001, p = 0.022). After 2019, MICD volumes increased more dramatically over the long term than would have been expected based on the pre-2019 trend (βpost = 0.0028, p < 0.001). However, supratentorial and infratentorial craniotomy volumes, as well as overall ICH evacuation volumes across all procedure types, showed no significant long-term change (p = 0.091, p = 0.18, p = 0.68, respectively). Conclusions The results of MISTIE III did not show a benefit of MICD over medical management for ICH with respect to the primary outcome of functional independence. We found that, despite these results, MICD evacuation procedure volumes increased significantly after the publication of the MISTIE III results. However, this association is only correlative, and other factors besides MISTIE III could have affected procedure volumes.
- 18 July 2026
- Published by Springer Nature in Cureus
- Vol. 18 (7)
Open AccessInvestigating Intracerebral Hemorrhage Evacuation Procedure Volumes Before and After the Minimally Invasive Surgery Plus Alteplase for Intracerebral Hemorrhage Evacuation III (MISTIE III) Trial
Introduction Intracerebral hemorrhage (ICH) constitutes 10-15% of all strokes in the United States and has a 30-40% mortality rate. The Minimally Invasive Surgery Plus Alteplase for Intracerebral Hemorrhage Evacuation III (MISTIE III) trial showed no significant functional benefit of minimally invasive catheter drainage (MICD) and postoperative thrombolysis compared to medical management. Our objective is to evaluate how the results of the MISTIE III trial corresponded to changes in ICH evacuation procedure volumes. Materials and methods We used an aggregated dataset containing Medicare Part B procedure data from 2013 to 2023. We calculated the normalized volume of MICD procedures, supratentorial craniotomies, and infratentorial craniotomies for ICH evacuation. We normalized the volumes by calculating the percentage of all neurosurgical procedures that included ICH evacuation for each year. We used an interrupted time series (ITS) to find statistically significant changes in volumes before (βpre) and after (βpost) 2019, when the MISTIE III results were published. Results Normalized MICD volumes increased slightly before 2019 (βpre = 0.0001, p = 0.022). After 2019, MICD volumes increased more dramatically over the long term than would have been expected based on the pre-2019 trend (βpost = 0.0028, p < 0.001). However, supratentorial and infratentorial craniotomy volumes, as well as overall ICH evacuation volumes across all procedure types, showed no significant long-term change (p = 0.091, p = 0.18, p = 0.68, respectively). Conclusions The results of MISTIE III did not show a benefit of MICD over medical management for ICH with respect to the primary outcome of functional independence. We found that, despite these results, MICD evacuation procedure volumes increased significantly after the publication of the MISTIE III results. However, this association is only correlative, and other factors besides MISTIE III could have affected procedure volumes.
- Open Access
- 3 July 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (3)
How Studies Influence Practice: Decompressive Lumbar Laminectomy Volumes Before and After Major Randomized Controlled Trials
Study Design: Retrospective cohort study. Objective: This study aimed to determine how decompressive lumbar laminectomy (DLL) procedure volumes changed after the publication of major randomized controlled trials (RCTs) that investigated the clinical efficacy of DLL. Summary of Background Data: Two RCTs published in 2015 and one published in 2018 demonstrated no benefit of DLL compared with nonoperative care in intention-to-treat analyses. However, it remains unclear how these RCTs have influenced clinical practice. Methods: After conducting a systematic literature review to identify major DLL RCTs, we analyzed DLL volumes in an aggregated data set that contains Medicare Part B procedure data from 2013 to 2023. Results: Throughout 2013 to 2023, normalized DLL procedure volumes generally decreased. Before the 2015 RCTs, the slope of the normalized DLL procedure volumes was −0.22, which then decreased to −0.26 after 2015 ( P P <0.0001). Conclusions: Normalized DLL procedure volumes generally decreased from 2013 to 2023, but the rate of decline accelerated after the publication of two RCTs in 2015 and decelerated after the publication of the 2018 RCT. Therefore, although clinical practice trends aligned directionally with the evidence, the magnitude and consistency of response to high-level evidence varied over time. Level of Evidence: Level IV.
- 3 July 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (3)
Open AccessHow Studies Influence Practice: Decompressive Lumbar Laminectomy Volumes Before and After Major Randomized Controlled Trials
Study Design: Retrospective cohort study. Objective: This study aimed to determine how decompressive lumbar laminectomy (DLL) procedure volumes changed after the publication of major randomized controlled trials (RCTs) that investigated the clinical efficacy of DLL. Summary of Background Data: Two RCTs published in 2015 and one published in 2018 demonstrated no benefit of DLL compared with nonoperative care in intention-to-treat analyses. However, it remains unclear how these RCTs have influenced clinical practice. Methods: After conducting a systematic literature review to identify major DLL RCTs, we analyzed DLL volumes in an aggregated data set that contains Medicare Part B procedure data from 2013 to 2023. Results: Throughout 2013 to 2023, normalized DLL procedure volumes generally decreased. Before the 2015 RCTs, the slope of the normalized DLL procedure volumes was −0.22, which then decreased to −0.26 after 2015 ( P P <0.0001). Conclusions: Normalized DLL procedure volumes generally decreased from 2013 to 2023, but the rate of decline accelerated after the publication of two RCTs in 2015 and decelerated after the publication of the 2018 RCT. Therefore, although clinical practice trends aligned directionally with the evidence, the magnitude and consistency of response to high-level evidence varied over time. Level of Evidence: Level IV.
- Open Access
- 29 June 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (26)
Idiopathic spinal intramedullary epidermoid cyst arising in the thoracic region: illustrative case
BACKGROUND: Spinal epidermoid cysts are rare tumors typically found in the lumbosacral region in the intradural extramedullary space. These tumors are usually caused by defects in neural tube closure or acquired through iatrogenic or traumatic insult, with either mechanism leading to the inclusion of epidermal cells in cystic compartments in the spine. Although benign, these cysts can cause symptoms including back pain and weakness, and patients often undergo resection. OBSERVATIONS: We present a unique case of an intramedullary spinal epidermoid cyst appearing in the T6–7 region of a 69-year-old male. Furthermore, subcutaneous epidermoid cysts within the same region as the spinal tumor were observed. A review of the literature revealed that while intramedullary spinal epidermoid cysts are rare, their concurrent appearance with subcutaneous cysts has not been observed, demonstrating the novelty of this case. LESSONS: This case demonstrates the possible occurrence of epidermoid cysts in the intramedullary space, in superior spinal regions, and in the older population. Additionally, such cysts should remain on the differential in individuals with myelopathic symptoms and associated subcutaneous inclusion cysts on the back. Careful imaging to guide diagnoses and surgical planning is crucial. https://thejns.org/doi/10.3171/CASE26313
- 29 June 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (26)
Open AccessIdiopathic spinal intramedullary epidermoid cyst arising in the thoracic region: illustrative case
BACKGROUND: Spinal epidermoid cysts are rare tumors typically found in the lumbosacral region in the intradural extramedullary space. These tumors are usually caused by defects in neural tube closure or acquired through iatrogenic or traumatic insult, with either mechanism leading to the inclusion of epidermal cells in cystic compartments in the spine. Although benign, these cysts can cause symptoms including back pain and weakness, and patients often undergo resection. OBSERVATIONS: We present a unique case of an intramedullary spinal epidermoid cyst appearing in the T6–7 region of a 69-year-old male. Furthermore, subcutaneous epidermoid cysts within the same region as the spinal tumor were observed. A review of the literature revealed that while intramedullary spinal epidermoid cysts are rare, their concurrent appearance with subcutaneous cysts has not been observed, demonstrating the novelty of this case. LESSONS: This case demonstrates the possible occurrence of epidermoid cysts in the intramedullary space, in superior spinal regions, and in the older population. Additionally, such cysts should remain on the differential in individuals with myelopathic symptoms and associated subcutaneous inclusion cysts on the back. Careful imaging to guide diagnoses and surgical planning is crucial. https://thejns.org/doi/10.3171/CASE26313
- Open Access
- 18 June 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (3)
Kyphoplasty Versus Vertebroplasty: An Analysis of Medicare Procedure Volumes, Payment, and Specialties From 2015 to 2023
Study Design: Retrospective cohort study. Objective: This study aimed to determine how kyphoplasty and vertebroplasty procedure volumes, specialty-specific usage, and payments have changed among the Medicare patient population from 2015 to 2023. Summary of Background Data: Vertebral augmentation procedures, specifically kyphoplasty and vertebroplasty, are used to treat vertebral compression fractures. Published studies have found kyphoplasties to be associated with lower rates of cement leakage and more favorable postoperative vertebral alignment, including improved local kyphotic angle. Methods: We used an aggregated data set that contains Medicare Part B procedure data at the physician level from 2015 to 2023 (n=1819 unique physicians total). We filtered for kyphoplasty and vertebroplasty Current Procedural Terminology codes, and then analyzed overall trends in procedure volume, payment, and specialty usage over time. We used statistical tests to identify differences in these parameters between kyphoplasty and vertebroplasty. Results: From 2015 to 2023, the total number of both kyphoplasty and vertebroplasty procedures decreased with a compound annual growth rate (CAGR) of −5.4% and −16.8%, respectively. In 2019, 2020, 2022, and 2023, there were more kyphoplasty procedures than vertebroplasty procedures ( P P <0.0001). The average payment amount for kyphoplasties slightly increased overall from 2015 to 2023, with a CAGR of 6.9%. Although previous studies have identified similar trends up until 2018, our study provides an updated understanding. Conclusions: Our analysis of a comprehensive Medicare data set found that kyphoplasties are more common than vertebroplasties, and the use of both procedures has decreased slightly over time. Diagnostic and interventional radiology both perform a large proportion of these procedures. Level of Evidence: Level IV.
- 18 June 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (3)
Open AccessKyphoplasty Versus Vertebroplasty: An Analysis of Medicare Procedure Volumes, Payment, and Specialties From 2015 to 2023
Study Design: Retrospective cohort study. Objective: This study aimed to determine how kyphoplasty and vertebroplasty procedure volumes, specialty-specific usage, and payments have changed among the Medicare patient population from 2015 to 2023. Summary of Background Data: Vertebral augmentation procedures, specifically kyphoplasty and vertebroplasty, are used to treat vertebral compression fractures. Published studies have found kyphoplasties to be associated with lower rates of cement leakage and more favorable postoperative vertebral alignment, including improved local kyphotic angle. Methods: We used an aggregated data set that contains Medicare Part B procedure data at the physician level from 2015 to 2023 (n=1819 unique physicians total). We filtered for kyphoplasty and vertebroplasty Current Procedural Terminology codes, and then analyzed overall trends in procedure volume, payment, and specialty usage over time. We used statistical tests to identify differences in these parameters between kyphoplasty and vertebroplasty. Results: From 2015 to 2023, the total number of both kyphoplasty and vertebroplasty procedures decreased with a compound annual growth rate (CAGR) of −5.4% and −16.8%, respectively. In 2019, 2020, 2022, and 2023, there were more kyphoplasty procedures than vertebroplasty procedures ( P P <0.0001). The average payment amount for kyphoplasties slightly increased overall from 2015 to 2023, with a CAGR of 6.9%. Although previous studies have identified similar trends up until 2018, our study provides an updated understanding. Conclusions: Our analysis of a comprehensive Medicare data set found that kyphoplasties are more common than vertebroplasties, and the use of both procedures has decreased slightly over time. Diagnostic and interventional radiology both perform a large proportion of these procedures. Level of Evidence: Level IV.
- Open Access
- 1 June 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (22)
Displacement of synthetic cranioplasty implant due to mechanical failure of titanium fixation plating: illustrative case
BACKGROUND: Cranioplasty is a common procedure following decompressive craniectomy for traumatic brain injury or stroke, among other reasons, in order to repair a skull defect. Cranioplasty failure is an infrequent occurrence, but in the case of synthetic implants, it is usually caused by infection and incorrect sizing. However, trauma-induced displacement, breakage, and deformities of cranioplasty implants are less common. OBSERVATIONS: The authors present a unique case of a cranioplasty failure due to displacement of a polyetheretherketone (PEEK) implant secondary to catastrophic breakage of the titanium fixation plates. The cause of displacement is unknown but is suspected to be trauma. A subsequent review of the literature contextualizes common reasons for failure among synthetic implants and suggests that fracture of synthetic implants or their fixation plates is extremely rare. LESSONS: The displacement of a PEEK cranioplasty implant due to breakage of titanium fixation plates is a rare, albeit possible, complication of this neurosurgical procedure. Lifestyle modifications are paramount to reduce trauma risk and resultant cranioplasty failure. The addition of miniplates may also reduce implant displacement risk. Finally, since rates of failure differ by material, careful consideration of the type of material used for the implant should be incorporated into neurosurgical planning. https://thejns.org/doi/10.3171/CASE2694
- 1 June 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (22)
Open AccessDisplacement of synthetic cranioplasty implant due to mechanical failure of titanium fixation plating: illustrative case
BACKGROUND: Cranioplasty is a common procedure following decompressive craniectomy for traumatic brain injury or stroke, among other reasons, in order to repair a skull defect. Cranioplasty failure is an infrequent occurrence, but in the case of synthetic implants, it is usually caused by infection and incorrect sizing. However, trauma-induced displacement, breakage, and deformities of cranioplasty implants are less common. OBSERVATIONS: The authors present a unique case of a cranioplasty failure due to displacement of a polyetheretherketone (PEEK) implant secondary to catastrophic breakage of the titanium fixation plates. The cause of displacement is unknown but is suspected to be trauma. A subsequent review of the literature contextualizes common reasons for failure among synthetic implants and suggests that fracture of synthetic implants or their fixation plates is extremely rare. LESSONS: The displacement of a PEEK cranioplasty implant due to breakage of titanium fixation plates is a rare, albeit possible, complication of this neurosurgical procedure. Lifestyle modifications are paramount to reduce trauma risk and resultant cranioplasty failure. The addition of miniplates may also reduce implant displacement risk. Finally, since rates of failure differ by material, careful consideration of the type of material used for the implant should be incorporated into neurosurgical planning. https://thejns.org/doi/10.3171/CASE2694
- Open Access
- 19 May 2026
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 35 (7) , 108665
Using clinical and thrombus characteristics to predict the etiology of ischemic stroke: An analysis of the INSIGHT registry
- 19 May 2026
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 35 (7) , 108665
Open AccessUsing clinical and thrombus characteristics to predict the etiology of ischemic stroke: An analysis of the INSIGHT registry
- Open Access
- 6 April 2026
- Published by Springer Nature in Scientific Data
- Vol. 13 (1)
Long non-coding RNA profiling of hypertrophic cardiomyopathy in mice
Long non-coding RNAs (lncRNAs) are transcripts that do not typically code for protein but have essential roles in the regulation of transcription and translation in health and disease. Hypertrophic cardiomyopathy (HCM) is a commonly inherited cardiovascular disease. While a number of studies have described transcriptional regulation in human heart tissue and animal models of HCM, whether lncRNA plays a role in the pathophysiology of HCM remains unknown. We present an RNA-Seq dataset on left ventricle samples from transgenic HCM TNNT2 ∆160 mice (n = 31) and non-transgenic (n = 33) mice (n = 64 total) in which differentially expressed lncRNAs are delineated. We determined the mouse lncRNA genes that have a human ortholog, which may be useful for future investigators aiming to study the role of particular lncRNAs in human HCM.
- 6 April 2026
- Published by Springer Nature in Scientific Data
- Vol. 13 (1)
Open AccessLong non-coding RNA profiling of hypertrophic cardiomyopathy in mice
Long non-coding RNAs (lncRNAs) are transcripts that do not typically code for protein but have essential roles in the regulation of transcription and translation in health and disease. Hypertrophic cardiomyopathy (HCM) is a commonly inherited cardiovascular disease. While a number of studies have described transcriptional regulation in human heart tissue and animal models of HCM, whether lncRNA plays a role in the pathophysiology of HCM remains unknown. We present an RNA-Seq dataset on left ventricle samples from transgenic HCM TNNT2 ∆160 mice (n = 31) and non-transgenic (n = 33) mice (n = 64 total) in which differentially expressed lncRNAs are delineated. We determined the mouse lncRNA genes that have a human ortholog, which may be useful for future investigators aiming to study the role of particular lncRNAs in human HCM.
- Open Access
- 14 February 2026
- Published by Springer Nature in Cureus
- Vol. 18 (2)
Tai Chi Interventions for Slowing Cognitive Decline in Mild Cognitive Impairment: A Review of Randomized Controlled Trials
The objective of this review was to compile randomized controlled trials that examined the effectiveness of tai chi in slowing cognitive decline among individuals with mild cognitive impairment (MCI). We limited our review to studies with interventions that lasted at least six months (≥ 24 weeks). Three databases were searched using similar search terms and inclusion/exclusion criteria to identify studies for review. In total, eight randomized controlled trials were included. The inclusion criteria limited the selected articles to RCTs whose patients all had MCI and were at risk for developing cognitive decline. All eight studies revealed that tai chi slows cognitive decline among patients with MCI across various domains, including memory, attention, and global cognition, compared to the control groups. Notably, improvements in patient cognition were consistently observed across studies. Three studies using the Montreal Cognitive Assessment revealed a greater increase in MoCA scores from baseline to follow-up (≥24 weeks) among the tai chi intervention group compared to the non-tai chi control group (0.84, 1.3, and 2.9). Similarly, two studies using the Mini-Mental State Examination found greater cognitive improvements among the tai chi group than in the control group from baseline to follow-up (0.60 and 0.48). In conclusion, this review supports tai chi as a promising intervention for slowing cognitive decline in individuals with MCI. Positive effects were observed across various cognitive assessments. Thus, these findings may help guide patient care strategies and inform clinical models for MCI management.
- 14 February 2026
- Published by Springer Nature in Cureus
- Vol. 18 (2)
Open AccessTai Chi Interventions for Slowing Cognitive Decline in Mild Cognitive Impairment: A Review of Randomized Controlled Trials
The objective of this review was to compile randomized controlled trials that examined the effectiveness of tai chi in slowing cognitive decline among individuals with mild cognitive impairment (MCI). We limited our review to studies with interventions that lasted at least six months (≥ 24 weeks). Three databases were searched using similar search terms and inclusion/exclusion criteria to identify studies for review. In total, eight randomized controlled trials were included. The inclusion criteria limited the selected articles to RCTs whose patients all had MCI and were at risk for developing cognitive decline. All eight studies revealed that tai chi slows cognitive decline among patients with MCI across various domains, including memory, attention, and global cognition, compared to the control groups. Notably, improvements in patient cognition were consistently observed across studies. Three studies using the Montreal Cognitive Assessment revealed a greater increase in MoCA scores from baseline to follow-up (≥24 weeks) among the tai chi intervention group compared to the non-tai chi control group (0.84, 1.3, and 2.9). Similarly, two studies using the Mini-Mental State Examination found greater cognitive improvements among the tai chi group than in the control group from baseline to follow-up (0.60 and 0.48). In conclusion, this review supports tai chi as a promising intervention for slowing cognitive decline in individuals with MCI. Positive effects were observed across various cognitive assessments. Thus, these findings may help guide patient care strategies and inform clinical models for MCI management.